corporary

GENEVOLUTION

Active
SIREN 835221342 VAT number FR02835221342

Business purpose.

La réalisation d'études sur des systèmes biologiques et en autres sciences physiques et naturelles en recherche et développement avec délivrance de résultats à des tiers du secteur pharmaceutique, cosmétiques, dispositifs médicaux,chimique et hospitalier. La caractérisation des cellules en cytogénétique et développement de nouveau modèle in vitro. Le commerce et fabrication d'équipement scientifique et technique,de machines spécialisées. Revente de matériel.Conseil et formation pour ses clients. Archivage selon les bonnes pratiques réglementaires (BPx), ou archivage de documents scientifiques.

Identity

Legal form
SAS, simplified joint-stock company
Activity
Other research and experimental development on natural sciences and engineering (72.19Z)
Sector
Scientific research and development
Headcount
10 to 19 employees
Created
8 Jan 2018
Share capital
7,145.00 EUR
Registered with the trade register
6 Feb 2018
Financial year end
31/12
Establishments
4

Directors

Related companies

Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.

Other companies at the same address

63 other company head offices are registered at this address.

Establishments

Financial strength

Financial score

14 / 100 E

Confidence: medium · computed on the financial year ended 31 Dec 2024

Equity to assets (2.4 %)
4.7 out of 30
EBITDA margin
data missing, component not taken into account
Liquidity (142.9 %)
5.7 out of 20
Debt (1,821.2 %)
0.0 out of 15
Revenue trend (-100.0 %)
0.0 out of 10

formula fin-1.0

Legal score

98 / 100 A

Confidence: high

No insolvency proceedings
40.0 out of 40
Currently trading
20.0 out of 20
Age (8.8 years)
17.7 out of 20
Accounts filed recently
20.0 out of 20

formula leg-1.0

These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated

Revenue and earnings

Detailed accounts for this company are not reproduced here, but its main aggregates are public.

Revenue and net income by financial year
2021 2024

Revenue Net income

Financial year Revenue Change EBITDA Net income
31 Dec 2024 0 € -100.0 % 0 € -180,971 €
31 Dec 2021 699,794 € first year on record -134,825 € -2,774 €

Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.

Explore similar companies

Collective agreements

Agreements declared by the employer in its payroll filings.

  • Convention collective nationale de la fabrication et du commerce des produits à usage pharmaceutique, parapharmaceutique et vétérinaire du 1er juin 1989. Etendue par arrêté du 20 avril 1990 JORF 29 avril 1990

    IDCC 1555 · repealed · 1 establishment · declared in July 2026

Legal notices

  • Filing of accounts 30 Jun 2025
    Court :
    Greffe du Tribunal des Activités Economiques de versailles
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2024

    BODACC C n 20250124, annonce n 10668 · Proof of publication (PDF)

  • Amendment 30 Jun 2025
    Court :
    Greffe du Tribunal des Activités Economiques de Versailles
    Amendment :
    Modification survenue sur l'administration, le capital.

    BODACC B n 20250124, annonce n 4208 · Proof of publication (PDF)

  • Amendment 30 Mar 2023
    Court :
    Greffe du Tribunal de Commerce de Versailles
    Amendment :
    Modification survenue sur l'administration.

    BODACC B n 20230063, annonce n 4926 · Proof of publication (PDF)

  • Amendment 2 Mar 2023
    Court :
    Greffe du Tribunal de Commerce de Versailles
    Amendment :
    Modification survenue sur le capital, transfert du siège social.

    BODACC B n 20230043, annonce n 4269 · Proof of publication (PDF)

  • Filing of accounts 30 Dec 2022
    Court :
    Greffe du Tribunal de Commerce de versailles
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2021

    BODACC C n 20220254, annonce n 3598 · Proof of publication (PDF)

  • Amendment 24 Oct 2021
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE VERSAILLES
    Amendment :
    Modification survenue sur l'activité.

    BODACC B n 20210208, annonce n 1614 · Proof of publication (PDF)

  • Filing of accounts 22 Jul 2021
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE VERSAILLES
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2020

    BODACC C n 20210141, annonce n 13684 · Proof of publication (PDF)

  • Amendment 3 Dec 2020
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE VERSAILLES
    Amendment :
    Modification survenue sur la dénomination.

    BODACC B n 20200235, annonce n 3560 · Proof of publication (PDF)

  • Amendment 22 Apr 2020
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE VERSAILLES
    Amendment :
    transfert du siège social.

    BODACC B n 20200079, annonce n 333 · Proof of publication (PDF)

Annual accounts as PDF →

Filings and accounts

  • Formality 28 Jun 2025
  • Formality 25 Jun 2025

Change history

  • officer_appointed (empty) → Directeur general 9 Oct 2026
  • officer_appointed (empty) → Commissaire aux comptes titulaire 9 Oct 2026
  • officer_appointed (empty) → President de SAS 9 Oct 2026
  • capital 7145.00 → 5328.00 2 Oct 2026
  • registered_address 4 Rue des Frères Montgolfiers 78710 Rosny-sur-Seine → 1560 Route de 40 sous 78630 Orgeval 2 Oct 2026
  • capital (empty) → 7145.00 2 Oct 2026
  • registered_address (empty) → 4 Rue des Frères Montgolfiers 78710 Rosny-sur-Seine 1 Oct 2026

Frequently asked questions about GENEVOLUTION

What is the SIREN number of GENEVOLUTION?
The SIREN number of GENEVOLUTION is 835221342. Its intra-community VAT number is FR02835221342.
Where is the head office of GENEVOLUTION?
Head office address: 1560 ROUTE DE 40 SOUS, 78630 ORGEVAL.
When was GENEVOLUTION founded?
GENEVOLUTION was founded on 8 Jan 2018.
What does GENEVOLUTION do?
Its declared main activity is: Other research and experimental development on natural sciences and engineering (NAF code 72.19Z).
Who runs GENEVOLUTION?
The officers listed in the register are GAUTIER DECOCK (Directeur general), EMERSON AUDIT (Commissaire aux comptes titulaire), ISABELLE MOUCHE (President de SAS).
What is the revenue of GENEVOLUTION?
The latest published revenue is 0 €, for the 2024 financial year.
How many employees does GENEVOLUTION have?
The declared headcount is 10 to 19 employees. Insee data for 2024.
Is GENEVOLUTION subject to insolvency proceedings?
No ongoing insolvency proceedings are published in the BODACC for this company.

In the official registers

Further reading

Show this profile on your website →

Report an error or request removal of this data